Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company") is pleased to announce that, further to its news release dated July 15, 2025, it has entered into a definitive share purchase agreement (the "Agreement") with Dare to be Different Foods, Inc. ("D2BD"), a U.S.-based company specializing in gluten-free, vegetable-forward food products, and the shareholders of D2BD (the "D2BD Shareholders") pursuant to which Eshbal will acquire a majority interest in D2BD (the "Transaction"). The execution of the Agreement reflects the next step in advancing Eshbal's strategic growth agenda.

Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company") is pleased to announce that it has entered into a sales and marketing agreement with Active Marketing Group ("AMG"), a leading U.S.-based consumer packaged goods marketing and brokerage firm.

Yuval Levy, Chairman of Eshbal Functional Food Inc. and Tomer Bar-Meir, Chief Executive Officer of Eshbal Functional Food Inc. ("Eshbal" or the "Company") (TSXV: ESBL), joined Yossi Boker, Head of Business Development, TMX Group, to open the market from Kibutz Maanit in Israel and celebrate the Company's new listing on TSX Venture Exchange.

Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company"), a developer of gluten-free and health-focused food products, today reported its first consolidated financial results following completion of its April 2025 reverse takeover (the "RTO") and provides a corporate update regarding ongoing business activities.

Israel-based Eshbal Functional Foods is banking on acquisitions in the North American market to drive growth and triple revenue in the next two years. The better-for-you bakery business gained a listing in Canada this year following a reverse takeover of Hakken Capital Corp. and is now preparing to take its gluten-free pitta bread into the US market with an expected launch in September.

("Eshbal" or the "Company"), a developer of gluten-free and health-focused food products, is pleased to share a set of strategic steps advancing its commercial and capital markets execution in North America:

1. the signing of a binding Letter of Intent with GF Nation Brand; and

2. the formal launch of the Company's investor relations program, including the appointment of a Head of Investor Communications.

("Eshbal" or the "Company"), a developer of gluten-free and health-focused food products, is pleased to announce key developments supporting its North American expansion strategy: the planned commercial launch of its U.S. produced gluten-free pita bread, and the asset acquisition of Swonder Bread, an Israeli-based bakery specializing in sprouted gluten-free sourdough products.

("Eshbal" or the "Company")(formerly Hakken Capital Corp. "Hakken") (TSXV: ESBL.V), is pleased to announce that on May 30, 2025, the Company reported the financial results for the quarter ending March 31, 2025, of its recently acquired (the "Acquisition") Israeli wholly owned subsidiary, Eshbal Functional Food (Agricultural Cooperative) Ltd. ("Eshbal Israel").